Literature DB >> 31015663

Engineered commensal microbes for diet-mediated colorectal-cancer chemoprevention.

Chun Loong Ho1,2, Hui Qing Tan3, Koon Jiew Chua1,2, Aram Kang1,2, Kiat Hon Lim4, Khoon Lin Ling3, Wen Shan Yew1,2, Yung Seng Lee2,5, Jean Paul Thiery1,2, Matthew Wook Chang6,7.   

Abstract

Chemoprevention-the use of medication to prevent cancer-can be augmented by the consumption of produce enriched with natural metabolites. However, chemopreventive metabolites are typically inactive and have low bioavailability and poor host absorption. Here, we show that engineered commensal microbes can prevent carcinogenesis and promote the regression of colorectal cancer through a cruciferous vegetable diet. The engineered commensal Escherichia coli bound specifically to the heparan sulphate proteoglycan on colorectal cancer cells and secreted the enzyme myrosinase to transform host-ingested glucosinolates-natural components of cruciferous vegetables-to sulphoraphane, an organic small molecule with known anticancer activity. The engineered microbes coupled with glucosinolates resulted in >95% proliferation inhibition of murine, human and colorectal adenocarcinoma cell lines in vitro. We also show that murine models of colorectal carcinoma fed with the engineered microbes and the cruciferous vegetable diet displayed significant tumour regression and reduced tumour occurrence.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 31015663     DOI: 10.1038/s41551-017-0181-y

Source DB:  PubMed          Journal:  Nat Biomed Eng        ISSN: 2157-846X            Impact factor:   25.671


  49 in total

Review 1.  Development of bacteria as diagnostics and therapeutics by genetic engineering.

Authors:  Daejin Lim; Miryoung Song
Journal:  J Microbiol       Date:  2019-05-11       Impact factor: 3.422

2.  A Meta-proteogenomic Approach to Peptide Identification Incorporating Assembly Uncertainty and Genomic Variation.

Authors:  Sujun Li; Haixu Tang; Yuzhen Ye
Journal:  Mol Cell Proteomics       Date:  2019-05-29       Impact factor: 5.911

3.  Engineering bacteria for cancer therapy.

Authors:  Tetsuhiro Harimoto; Tal Danino
Journal:  Emerg Top Life Sci       Date:  2019-11-11

Review 4.  Engineering microbial diagnostics and therapeutics with smart control.

Authors:  Matthew B Amrofell; Austin G Rottinghaus; Tae Seok Moon
Journal:  Curr Opin Biotechnol       Date:  2020-06-18       Impact factor: 9.740

5.  Characterization of Lysozyme-Like Effector TseP Reveals the Dependence of Type VI Secretion System (T6SS) Secretion on Effectors in Aeromonas dhakensis Strain SSU.

Authors:  Xiaoye Liang; Tong-Tong Pei; Zeng-Hang Wang; Weiliang Xiong; Li-Li Wu; Ping Xu; Shuangjun Lin; Tao G Dong
Journal:  Appl Environ Microbiol       Date:  2021-05-26       Impact factor: 4.792

6.  Towards a cancer-chemopreventive diet.

Authors:  David A Drew; Andrew T Chan
Journal:  Nat Biomed Eng       Date:  2018-01       Impact factor: 25.671

Review 7.  Beyond the Green Fluorescent Protein: Biomolecular Reporters for Anaerobic and Deep-Tissue Imaging.

Authors:  Harun F Ozbakir; Nolan T Anderson; Kang-Ching Fan; Arnab Mukherjee
Journal:  Bioconjug Chem       Date:  2019-12-23       Impact factor: 4.774

Review 8.  Biosensing in Smart Engineered Probiotics.

Authors:  Austin G Rottinghaus; Matthew B Amrofell; Tae Seok Moon
Journal:  Biotechnol J       Date:  2020-01-07       Impact factor: 4.677

9.  Host-Microbe-Drug-Nutrient Screen Identifies Bacterial Effectors of Metformin Therapy.

Authors:  Rosina Pryor; Povilas Norvaisas; Georgios Marinos; Lena Best; Louise B Thingholm; Leonor M Quintaneiro; Wouter De Haes; Daniela Esser; Silvio Waschina; Celia Lujan; Reuben L Smith; Timothy A Scott; Daniel Martinez-Martinez; Orla Woodward; Kevin Bryson; Matthias Laudes; Wolfgang Lieb; Riekelt H Houtkooper; Andre Franke; Liesbet Temmerman; Ivana Bjedov; Helena M Cochemé; Christoph Kaleta; Filipe Cabreiro
Journal:  Cell       Date:  2019-08-29       Impact factor: 41.582

Review 10.  Aspirin in the Prevention of Colorectal Neoplasia.

Authors:  David A Drew; Andrew T Chan
Journal:  Annu Rev Med       Date:  2020-10-09       Impact factor: 13.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.